Nine of Ten Women Cannot Quantify Lifetime Breast Cancer Risk

More than 90% of women about to undergo a mammography were unable to accurately quantify their risk for breast cancer, either over- or underestimating their risk, according to the results of a large-scale survey presented at the ASCO Breast Cancer Symposium 2013.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news

Related Links:

Abstract BACKGROUND: Massage therapy's ability to mitigate breast imaging associated anxiety has not been previously studied. Anxiety is, however, often cited as a harm of screening mammography with few options offered to diminish anxiety other than not screening. Reducing anxiety may improve compliance, and reduce breast cancer mortality and morbidity. A complimentary massage therapy program evaluated patient acceptance, anxiety perception and perceived value of massage. METHODS: Over 10 weeks, verbal agreement was obtained from 113 breast imaging patients who desired a hand or shoulder/neck massage. Li...
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Clin Imaging Source Type: research
AbstractBreast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women ’s attendance to organised mammography screening as well as to advances in therapies, especially systemic treatments. Screening attendance is associated with a mortality reduction of at least 30% and a 40% lower risk of advanced disease. The stage at diagnosis remains the strongest predictor of re currences. Systemic treatments evolved dramatically over the last 20 years: aromatase inhibitors...
Source: Insights into Imaging - Category: Radiology Source Type: research
This article summarizes the effect of the global pandemic – and efforts to curtail its spread – on both breast cancer care and on breast imaging pract ices including effects on patients, clinical workflow, education and research.
Source: Radiologic Clinics of North America - Category: Radiology Authors: Source Type: research
Abstract The purpose of this article is to overview the existing breast cancer screening guidelines for women at high risk from world-leading specialty societies. Accumulation of evidence and development of accessible genetic testing strategies have changed the idea of breast cancer screening for high-risk women. Personalized tailor-made screening adjusted for risk factors has been conducted in accordance with guidelines. The use of imaging modalities other than mammography including contrast-enhanced MRI and other various strategies for improving screening are discussed. The present review also mentions the exist...
Source: Breast Cancer - Category: Cancer & Oncology Authors: Tags: Breast Cancer Source Type: research
Contrast-enhanced mammography (CEM) combines conventional mammography with iodinated contrast material to improve cancer detection. CEM has comparable performance to breast MRI without the added cost or time of conventional MRI protocols. Thus, this technique may be useful for indications previously reserved for MRI, such as problem-solving, determining disease extent in patients with newly diagnosed cancer, monitoring response to neoadjuvant therapy, evaluating the posttreatment breast for residual or recurrent disease, and potentially screening in women at intermediate- or high-risk for breast cancer.
Source: Clinical Imaging - Category: Radiology Authors: Tags: Breast Imaging Source Type: research
Evaluation of reconstruction algorithms for a stationary digital breast tomosynthesis system using a carbon nanotube X-ray source array. J Xray Sci Technol. 2020 Sep 10;: Authors: Hu Z, Chen Z, Zhou C, Hong X, Chen J, Zhang Q, Jiang C, Ge Y, Yang Y, Liu X, Zheng H, Li Z, Liang D Abstract Breast cancer is the most frequently diagnosed cancer in women worldwide. Digital breast tomosynthesis (DBT), which is based on limited-angle tomography, was developed to solve tissue overlapping problems associated with traditional breast mammography. However, due to the problems associated with tube movement dur...
Source: Journal of X-Ray Science and Technology - Category: Radiology Tags: J Xray Sci Technol Source Type: research
ConclusionsOur data indicate  a high rate of non-adherence to guidelines, physicians recommending extensive systemic evaluation for women with early breast cancer. These deviations from the guidelines are associated with subjective factors, some of them being physician-dependent. Initiatives aimed at improving adherence to g uidelines, and specifically to guidelines recommending"doing less" should therefore include not just knowledge-based education but also encourage conversation about what is appropriate and necessary.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
Cancer screening uses many investigative procedures, and different screening programs and methods have different objectives. For example, mammography aims to detect breast cancer at an earlier stage when successful treatment is more likely, whereas colonoscopy is aimed primarily at detecting adenomas in the colon and removing them, thus preventing them from progressing to cancer at all. Evaluation has different objectives, including proof of principle, checking that screening services are delivering the desired clinical outcome, technical quality control of the investigation procedures. All necessitate a range of tools for...
Source: Medical Clinics of North America - Category: Primary Care Authors: Source Type: research
ConclusionBoth patients and PCPs perceived a need for tools to relay technical and process knowledge about mammography prior to clinical encounters to address the scope of information that patients with limited health literacy desired.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
In Reply In their letter about our cluster randomized clinical trial of a mammography screening decision aid (DA) for women 75 years and older, Donzelli and Giudicatti recommended that the DA be more explicit about the lack of data that mammography screening extends life. To inform the DA, we reviewed outcomes from mammography screening trials and from simulation models. A 2016 meta-analysis of mammography screening trials found a 33% reduction in breast cancer mortality with screening for women 60 to 69 years (risk ratio [RR], 0.67 [95% CI, 0.54-0.83]) and a 20% reduction in breast cancer mortality for women 70 to 74 year...
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Mammography | Women